Inhibikase Therapeutics Inc. buy krebskrebs
Start price
21.03.22
/
50%
€1.25
Target price
21.03.23
€2.00
Performance (%)
-56.00%
End price
22.03.23
€0.55
Summary
This prediction ended on 22.03.23 with a price of €0.55. The BUY prediction by krebskrebs for Inhibikase Therapeutics Inc. performed very badly with a performance of -56.00%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Inhibikase Therapeutics Inc. | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by krebskrebs for this prediction
In the thread Inhibikase Therapeutics Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Inhibikase Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten